Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jaillon

Showing results (21-30 of 195) with videos related to

Pageof 20
Sort By:
Therapie|May 1, 1992
[Ventricular pro-arrhythmic effects of anti-arrhythmia drugs]P Jaillon, T Simon
European Heart Journal|February 1, 1988
How do kinetics relate to toxicity of antiarrhythmic drugs?P Jaillon, A Ferry
Therapie|March 1, 1984
[Beta-blockers and secondary prevention after myocardial infarction]A Kher, P Jaillon
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1991
[Methodology in clinical trials of anti-arrhythmia agents in ventricular arrhythmias. Analysis and perspective following results of the CAST study]P Jaillon, B Dupuis
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 27, 2001
[Hormone replacement therapy and cardiovascular risk in menopausal women]T Simon, P Jaillon
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1989
[Prerequisites for phase I and phase II clinical trials of drugs]P Jaillon, B Dupuis
The American Journal of Cardiology|December 5, 1989
Recent antiarrhythmic drugsP Jaillon, M Drici
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1989
[The effect of cardiac insufficiency on pharmacokinetics]G Cheymol, P Jaillon
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1980
Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogsP Jaillon, R E Kates
The American Journal of Cardiology|August 26, 1993
Rate-corrected QT interval: techniques and limitationsC Funck-Brentano, P Jaillon
Pageof 20

Showing results (21-30 of 195) with videos related to

Sort By:
Pageof 20
Therapie|May 1, 1992
[Ventricular pro-arrhythmic effects of anti-arrhythmia drugs]P Jaillon, T Simon
European Heart Journal|February 1, 1988
How do kinetics relate to toxicity of antiarrhythmic drugs?P Jaillon, A Ferry
Therapie|March 1, 1984
[Beta-blockers and secondary prevention after myocardial infarction]A Kher, P Jaillon
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1991
[Methodology in clinical trials of anti-arrhythmia agents in ventricular arrhythmias. Analysis and perspective following results of the CAST study]P Jaillon, B Dupuis
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 27, 2001
[Hormone replacement therapy and cardiovascular risk in menopausal women]T Simon, P Jaillon
Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1989
[Prerequisites for phase I and phase II clinical trials of drugs]P Jaillon, B Dupuis
The American Journal of Cardiology|December 5, 1989
Recent antiarrhythmic drugsP Jaillon, M Drici
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 1, 1989
[The effect of cardiac insufficiency on pharmacokinetics]G Cheymol, P Jaillon
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1980
Phenytoin-induced changes in quinidine and 3-hydroxyquinidine pharmacokinetics in conscious dogsP Jaillon, R E Kates
The American Journal of Cardiology|August 26, 1993
Rate-corrected QT interval: techniques and limitationsC Funck-Brentano, P Jaillon
Pageof 20